Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ADR-001 in Decompensated Liver Cirrhosis
NCT03254758Phase 2Completed
- Sponsor
- Rohto Pharmaceutical Co., Ltd.
- Start
- Jul 2017
- Primary completion
- Apr 2023
- Modality
- Mesenchymal Stem Cells
- Countries
- 1
01
Overview
A Phase 2 trial of ADR-001 in Liver cirrhosis (LC), sponsored by Rohto Pharmaceutical Co., Ltd.. Started Jul 2017; status: completed.
02
Drugs
ADR-001
03
Conditions
Liver cirrhosis (LC)
Beyond the preview
Go deeper on NCT03254758.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03254758.